Latest news
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM) - Yahoo FinanceYahoo Finance · Mon, 27 Jul 2026 07:00:00 GMTLexicon's HCM study spans 20 countries; results anticipated Q1 2027 - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT